Patents by Inventor Nigel Phillip Taylor

Nigel Phillip Taylor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Production of rosuvastatin calcium salt
    Patent number: 8063213
    Abstract: An improved process for the manufacture of (E)-7-[4-(4-flurophenyl)-6-isopropyl-2-[methyl(methylsulfony)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid calcium salt, Formula (1), which is useful for the production of a pharmaceutical useful in the treatment of, inter alia, hypercholesterolemia, hyperlipoproteinemia and atherosclerosis, is described.
    Type: Grant
    Filed: June 3, 2004
    Date of Patent: November 22, 2011
    Assignee: AstraZeneca UK Limited
    Inventors: Jeffrey Norman Crabb, John Horbury, Nigel Phillip Taylor
  • Production of Rosuvastatin Calcium Salt
    Publication number: 20080221323
    Abstract: An improved process for the manufacture of (E)-7-[4-(4-flurophenyl)-6-isopropyl-2-[methyl(methylsulfony)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid calcium salt, Formula (1), which is useful for the production of a pharmaceutical useful in the treatment of, inter alia, hypercholesterolemia, hyperlipoproteinemia and atherosclerosis, is described.
    Type: Application
    Filed: June 3, 2004
    Publication date: September 11, 2008
    Inventors: Jeffrey Norman Crabb, John Horbury, Nigel Phillip Taylor
  • Chemical process
    Publication number: 20040101864
    Abstract: A process for the preparation of a salt of 5-phenylpentanoyl-(S)-arginyl-(S)-alanyl-{(S)-2-[(R)-3-amino-2-oxopyrrolidin-1-yl]propionyl}-(S)-alanyl-(S)-arginyl-(S)-alanyl-4-aminophenylacetamide (SEQ ID NO: 1) which comprises deprotection of a compound of the formula II or a salt thereof: wherein Pg and R1 are defined in the description. Also claimed are intermediates used in the process and the processes for the preparation of the intermediates.
    Type: Application
    Filed: June 24, 2003
    Publication date: May 27, 2004
    Applicant: AtraZeneca AB
    Inventors: Nigel Phillip Taylor, Kevin William Leslie, Phillip John Hogan, Francis Joseph Montgomery, Edward John Bush, Kay Alison Boardman, Claire Ingrid Pulling, Alan Charles Barker